Navigation Links
Dyadic International Reports 2010 Third Quarter Financial Results
Date:11/15/2010

enzyme yields at lower cost for the benefit of our licensing and research partners
  • Initiated several provisional patent applications on genes and the enzymes they encode which resulted from ongoing research generated through the Scripps annotation program

  • Intellectual Property

  • Sixth U.S. patent issued to Dyadic in October 2010

  • Financial ResultsTotal revenue for the third quarter ended September 30, 2010 decreased to approximately $2.0 million as compared to approximately $2.1 million for the third quarter ended September 30, 2009. Total revenue for the nine months ended September 30, 2010 decreased to approximately $6.2 million as compared to approximately $19.0 million for the nine months ended September 30, 2009. The decrease in total revenue for the three and nine month periods ended September 30, 2010 as compared to the three and nine month periods ended September 30, 2009 was due to a decrease in license fee revenue and research and development revenue as described below.

    Net product related revenue for the third quarter increased approximately 15% to approximately $2.0 million as compared to approximately $1.7 million for the third quarter of 2009. Net product related revenue for the nine months ended September 30, 2010 increased approximately 14% to approximately $5.5 million as compared to approximately $4.9 million for the same period a year ago.

    Gross margins for net product related revenue (exclusive of shipping and other costs) for the nine months ended September 30, 2010 increased to approximately 31% as compared to approximately 22% for the nine months ended September 30, 2009 as a result of the continued focus on more profitable product lines and improvements to inventory management and overall operating efficiencies.

    There was no license fee revenue for the third quarter ended September 30, 2010 as compared to license fee revenue of $125,000 for the third quarter ended September 30, 2009
    '/>"/>

    SOURCE Dyadic International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
    2. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
    3. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
    4. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
    5. Dyadic International Engages The Abraham Group as Strategic Advisor
    6. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
    7. Dyadic International Strengthens Management Team
    8. Dyadic International Extends Collaboration With The Scripps Research Institute
    9. International Technidyne Corporation Acquired by Warburg Pincus
    10. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
    11. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... Opertech Bio, Inc., a company that ... approach to sensory evaluation, today announced the issuance ... Patent and Trademark Office, encompassing high-throughput sensory discrimination ... taste evaluation technology called Microtiter Operant Gustometer or ... for rapid characterization of taste sensory properties,” said ...
    (Date:9/2/2014)... , Sept. 2, 2014  Synthetic Biologics, ... anti-infective biologic and drug candidates targeting specific pathogens ... positive results from its final preclinical toxicology study ... (FDA) guidance, this bridging study was required to ... designed to prevent the devastating effects of ...
    (Date:9/2/2014)... 2, 2014 Culot brings life ... lab management services  BioData, producer of Labguru, ... to announce the appointment of Louis Culot ... as VP Marketing and Business Development at BioDiscovery Inc., ... clinical applications. Previously, Culot worked for 17 ...
    (Date:9/1/2014)... NewYork (PRWEB) September 01, 2014 ... Biotech and Diagnostics report provides comprehensive understanding and ... agreements entered into by the worlds leading life ... understand and analysis of how and why companies ... of a prospective partner’s negotiated deals terms provides ...
    Breaking Biology Technology:Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5Louis Culot Appointed as BioData's CEO 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 4
    ... has closed the nominations for the 2011 Life Science ... 2011, hundreds of scientists on The Science Advisory Board® ... the ballot to determine the recipients of the prestigious ... survey, will be available to fill out between September ...
    ... Mass. and TORONTO, Sept. 21, 2011 Generex Biotechnology ... Express, Inc. ( www.antigenexpress.com ), today announced that its ... in Phase II development for the treatment of breast ... Scientific American , in a story titled "A ...
    ... Wales, Sept. 21, 2011 Genesis Biosciences, a ... and antimicrobial product development, announced today that Casey ... operations. Additionally, Mauricio Amaya and Amit Choksi have ... respectively, and Prasanth Maddipati joins Genesis as a ...
    Cached Biology Technology:BioInformatics LLC Announces the Nominees for the 2011 Life Science Industry Awards® 2BioInformatics LLC Announces the Nominees for the 2011 Life Science Industry Awards® 3BioInformatics LLC Announces the Nominees for the 2011 Life Science Industry Awards® 4Antigen Express' AE37 Cancer Vaccine Featured in Scientific American 2Antigen Express' AE37 Cancer Vaccine Featured in Scientific American 3Antigen Express' AE37 Cancer Vaccine Featured in Scientific American 4Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff 2Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff 3Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff 4
    (Date:9/2/2014)... the University of Warwick in the UK and the ... Journal Early Human Development , has found that ... birth and the use of mechanical ventilation are key ... Mathematic abilities are crucial for lifelong academic attainment. Impairments ... Earlier studies of children who are born very preterm ...
    (Date:9/2/2014)... that migrate by night tend to fly faster in ... destinations. This seasonal difference in flight speed is especially ... says researcher Cecilia Nilsson of Lund University in Sweden, ... , Nilsson, in a group led by professor ... three years the speed by which birds flew over ...
    (Date:9/2/2014)... spiky legs and their propensity for eating anything, including ... And now research from North Carolina State University finds ... across the eastern United States. , "The good news ... kind of threat to humans," says Dr. Mary Jane ... author of a paper about the research. , The ...
    Breaking Biology News(10 mins):Mechanical ventilation a key indicator for pre-term children's math problems 2Migrating birds sprint in spring, but take things easy in autumn 2Researchers find Asian camel crickets now common in US homes 2
    ... researchers and their colleagues have identified the gene that is ... called paraganglioma (PGL). The gene, called hSDH5, is required for ... in the chemical reactions that take place within cells to ... published in the journal Science , to be released ...
    ... that reveal some of the attributes of the long-lived leaves ... relatively large and are constructed of tough tissues," said Marler. ... leaf form are substantial." Green leaves must pay back ... to supply the energy needed to maintain its live tissues ...
    ... KNOXVILLE, Tenn. Consider the case of the three-spine ... in fresh water might appear to be the same, ... diverse collection of very specialized individuals. Understanding ... is the goal of a group of scientists meeting ...
    Cached Biology News:Scientists discover gene mutation responsible for hereditary neuroendocrine tumor 2Scientists discover gene mutation responsible for hereditary neuroendocrine tumor 3High construction cost for cycads 2The value of variation: Ecologists consider the causes and consequences 2
    ... Monoclonal Mouse Antibody to Cytokeratin 5 / ... a high molecular weight, basic type of ... the superficial cell layers of stratified epithelia ... and in mesothelial cells and mesothelioma. Cytokeratin ...
    Bovine Coronary Artery Endothelial Cells (BCAEC) (>500,000 cells)...
    Bovine Renal Artery Endothelial Cells (BRAEC) (>500,000 cells)...
    Bovine Aortic Smooth Muscle Cells (BAOSMC) (>500,000 cells)...
    Biology Products: